Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.7 |
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.061 | 0.7 |
mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |